EPO and polycythemia: However, other studies observed reduction in bone volume but without an increase in osteoclast activity in C57BL/6 mice given exogenous EPO (Suresh et al., 2019a) or in C57BL/6 mice transplanted with bone marrow from Tg6-mice to induce polycythemia (Oikonomidou et al., 2016).